IE40794B1 - Influenza vaccines - Google Patents

Influenza vaccines

Info

Publication number
IE40794B1
IE40794B1 IE59/75A IE5975A IE40794B1 IE 40794 B1 IE40794 B1 IE 40794B1 IE 59/75 A IE59/75 A IE 59/75A IE 5975 A IE5975 A IE 5975A IE 40794 B1 IE40794 B1 IE 40794B1
Authority
IE
Ireland
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Application number
IE59/75A
Other languages
English (en)
Other versions
IE40794L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE40794L publication Critical patent/IE40794L/xx
Publication of IE40794B1 publication Critical patent/IE40794B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
IE59/75A 1974-01-14 1975-01-13 Influenza vaccines IE40794B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (enrdf_load_html_response) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
IE40794L IE40794L (en) 1975-07-14
IE40794B1 true IE40794B1 (en) 1979-08-15

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
IE59/75A IE40794B1 (en) 1974-01-14 1975-01-13 Influenza vaccines

Country Status (27)

Country Link
JP (2) JPS58407B2 (enrdf_load_html_response)
AT (1) AT345449B (enrdf_load_html_response)
AU (1) AU500250B2 (enrdf_load_html_response)
BE (1) BE824372A (enrdf_load_html_response)
CA (1) CA1049406A (enrdf_load_html_response)
CH (1) CH589453A5 (enrdf_load_html_response)
CS (1) CS191254B2 (enrdf_load_html_response)
DD (1) DD116239A5 (enrdf_load_html_response)
DE (1) DE2500785B2 (enrdf_load_html_response)
DK (1) DK140003B (enrdf_load_html_response)
ES (1) ES433759A1 (enrdf_load_html_response)
FI (1) FI54053C (enrdf_load_html_response)
FR (1) FR2257305B1 (enrdf_load_html_response)
GB (1) GB1498261A (enrdf_load_html_response)
HK (1) HK56380A (enrdf_load_html_response)
HU (1) HU173920B (enrdf_load_html_response)
IE (1) IE40794B1 (enrdf_load_html_response)
IL (1) IL46426A (enrdf_load_html_response)
MY (1) MY8100204A (enrdf_load_html_response)
NL (1) NL166622C (enrdf_load_html_response)
NO (1) NO143128C (enrdf_load_html_response)
PH (1) PH14458A (enrdf_load_html_response)
PL (1) PL93689B1 (enrdf_load_html_response)
SE (1) SE427238B (enrdf_load_html_response)
SU (1) SU616997A3 (enrdf_load_html_response)
YU (1) YU41289B (enrdf_load_html_response)
ZA (1) ZA75259B (enrdf_load_html_response)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
US10655108B2 (en) * 2005-11-01 2020-05-19 Seqirus UK Limited Cell-derived viral vaccines with low levels of residual cell DNA
HRP20140375T1 (hr) * 2007-08-28 2014-06-20 Baxter International Inc. Postupak za proizvodnju virusnih cjepiva
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
NO143128B (no) 1980-09-15
AU500250B2 (en) 1979-05-17
JPS6035326B2 (ja) 1985-08-14
AT345449B (de) 1978-09-11
PH14458A (en) 1981-07-29
FI750014A7 (enrdf_load_html_response) 1975-07-15
CS191254B2 (en) 1979-06-29
AU7730575A (en) 1976-07-15
NO750031L (enrdf_load_html_response) 1975-08-11
YU41289B (en) 1987-02-28
YU5875A (en) 1984-04-30
CH589453A5 (enrdf_load_html_response) 1977-07-15
DE2500785A1 (de) 1975-07-31
JPS56127319A (en) 1981-10-06
DK1475A (enrdf_load_html_response) 1975-09-01
DK140003C (enrdf_load_html_response) 1979-10-29
JPS58407B2 (ja) 1983-01-06
NL7500301A (nl) 1975-07-16
HU173920B (hu) 1979-09-28
FR2257305B1 (enrdf_load_html_response) 1982-03-19
SU616997A3 (ru) 1978-07-25
MY8100204A (en) 1981-12-31
NL166622B (nl) 1981-04-15
DK140003B (da) 1979-06-05
FR2257305A1 (enrdf_load_html_response) 1975-08-08
FI54053C (fi) 1978-10-10
ES433759A1 (es) 1977-02-16
GB1498261A (en) 1978-01-18
IE40794L (en) 1975-07-14
SE427238B (sv) 1983-03-21
SE7500130L (enrdf_load_html_response) 1975-07-15
IL46426A0 (en) 1975-04-25
HK56380A (en) 1980-10-16
DE2500785C3 (enrdf_load_html_response) 1980-09-11
DE2500785B2 (de) 1980-01-03
NO143128C (no) 1980-12-29
ATA21475A (de) 1978-01-15
JPS50100224A (enrdf_load_html_response) 1975-08-08
FI54053B (fi) 1978-06-30
PL93689B1 (enrdf_load_html_response) 1977-06-30
BE824372A (fr) 1975-07-14
CA1049406A (en) 1979-02-27
DD116239A5 (enrdf_load_html_response) 1975-11-12
IL46426A (en) 1978-01-31
ZA75259B (en) 1976-08-25
NL166622C (nl) 1981-09-15

Similar Documents

Publication Publication Date Title
Schierman et al. Adjuvant activity of erythrocyte isoantigens
von Magnus Incomplete forms of influenza virus
Haslam et al. The structural proteins of Newcastle disease virus
IE40794L (en) Influenza vaccine.
Lahelle et al. Hemagglutination with the GDVII strain of mouse encephalomyelitis virus
US3674864A (en) Process for stabilizing preparations of interfering viruses
US20090035837A1 (en) Virus Production
IE781880L (en) Immunogenic herpes virus subunit
Hirst et al. A new method for concentrating influenza virus from allantoic fluid
Bang Filamentous forms of Newcastle virus
IE40180B1 (en) Influenza virus vaccines and preparation thereof
GB2001326A (en) Glycoproteins from paramyxovirus and vaccines therefrom
Mims Rift Valley fever virus in mice. II. Adsorption and multiplication of virus
IE40221B1 (en) Influenza vaccines
AU5573196A (en) A pluripotent vaccine against enveloped viruses
GB660109A (en) Improvements in or relating to the treatment of allantoic fluid containing a propagated virus together with non-viral proteins to obtain the virus in purified and viable from for use in a vaccine
GB1140316A (en) Influenza virus sub-unit vaccine
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
GB777018A (en) Poliomyelitis vaccine products and methods for preparing the same
郭元吉 et al. Influenza C virus isolated from pigs in China
IE42043L (en) Influenza type b virus vaccines.
Klamm et al. Neuraminidase activity and antigenicity of the egg adapted strains of mumps virus
AR120296A1 (es) Vacuna de partículas de virus de tipo chikungunya y sus métodos de uso
IE33734L (en) Antigenic material
ES384308A3 (es) Procedimiento para la preparacion de vacunas antigripales.